Corcept Therapeutics (CORT) Times Interest Earned (2010 - 2026)
Corcept Therapeutics (CORT) posted Times Interest Earned of $3.73 for Q2 2026, up 186.36% sequentially from -$4.32 in Q1 2026, and up 13.49% YoY from $3.29 in Q2 2025.
Corcept Therapeutics (CORT) Times Interest Earned (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Times Interest Earned for 17 years, with the latest figure at $3.73 in Q2 2026.
- Quarterly Times Interest Earned rose 13.49% year-over-year to $3.73 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $0.58 (down 95.39% YoY) and the FY2025 annual result came in at $2.14, down 72.71% from the prior year.
- Times Interest Earned grew to $3.73 in Q2 2026 per CORT's latest filing, from -$4.32 in the prior quarter.
- Over five years, Times Interest Earned peaked at $2243.5 in Q4 2025 and troughed at -$4.32 in Q1 2026.
- A 5-year average of $130.47 and a median of $3.6 in 2026 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2025 and 2026: Times Interest Earned jumped 154961.0% in 2025, then tumbled 1173.11% in 2026.
- Over 5 years, Times Interest Earned stood at $9.93 in 2022, then soared by 33.34% to $13.25 in 2023, then tumbled by 89.08% to $1.45 in 2024, then surged by 154961.0% to $2243.5 in 2025, then plunged by 99.83% to $3.73 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $3.73, -$4.32, and $2243.5 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 3.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.73 |
| Mar 31, 2026 | -4.32 |
| Dec 31, 2025 | 2,243.50 |
| Sep 30, 2025 | 1.32 |
| Jun 30, 2025 | 3.29 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 1.45 |
| Sep 30, 2024 | 5.34 |
| Jun 30, 2024 | 4.08 |
| Mar 31, 2024 | 47.81 |
| Dec 31, 2023 | 13.25 |
| Sep 30, 2023 | 3.00 |
| Jun 30, 2023 | 2.99 |
| Mar 31, 2023 | 1.60 |
| Dec 31, 2022 | 9.93 |
| Sep 30, 2022 | 3.80 |
| Jun 30, 2022 | 3.88 |
| Mar 31, 2022 | 3.48 |
| Dec 31, 2021 | 2.83 |
| Sep 30, 2021 | 5.03 |